510(k) Report

510(k) · Cleared

Cleared

Immunochemistry System Beta-2-Microglobulin Reagent

K973813510(k) TraditionalCleared Nov 20, 199744-day reviewClass II21 CFR 866.5630

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Beckman Instruments, Inc. · JZG System, Test, Beta-2-Microglobulin Immunological

Cleared on Nov 20, 1997 as substantially equivalent to K940353 (Beckman Instruments, Inc., 1994) after a 44-day review. Its family tree reaches back 1 generation to 1994.

Decided
Nov 20, 1997
Review
44 days
Class
Class II
Product code
JZG
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K940353 (1994). No later device cites it as a predicate yet.

K940353 · Beckman Beta-2-Microglobulin (B2M) · Beckman Instruments, Inc. · 199419901992199419961998
  1. Root · 1 generation backK940353 Beckman Beta-2-Microglobulin (B2M)Beckman Instruments, Inc. · 1994
  2. This deviceK973813 Immunochemistry System Beta-2-Microglobulin ReagentBeckman Instruments, Inc. · 1997
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K940353Beckman Beta-2-Microglobulin (B2M)Beckman Instruments, Inc.1994—
0 (this device)K973813Immunochemistry System Beta-2-Microglobulin ReagentBeckman Instruments, Inc.1997—
FIG. 1 — Lineage of K973813, 1994–1997Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JZG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K940353Beckman Beta-2-Microglobulin (B2M)
Summary page 1
…3.2 Classification Name Beta-2-microglobulin immunological test system (21 CFR § 866.5630) Docket | IMMAGE System Beta- | Amay Systems Beta-2- Beckman instruments, | K940353 | 2-Microglobulin (B2M) Microglobulin(B2M) Inc. Description: The IMMAGE Immunochemistry System B2M Reagent in conjunction with…
Beckman Instruments, Inc.1994—

Also cleared against K940353: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 2 other devices also cite its predicate K940353.

How does its category compare?

All JZG devices

JZG System, Test, Beta-2-Microglobulin Immunological: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JZG

1in 2016

2007: 22009: 22012: 22016: 1
2007high 2 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JZG

Too few JZG 510(k)s in any year since 2007 to give a median.

Recalls per year · JZG

1in 2024

2015: 12021: 12024: 1
2007high 1 (2015) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JZG

1in 2024

2015: 502019: 12024: 1
2007high 50 (2015) · low 0 (2007)2025

MAUDE reports naming product code JZG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20080—00
20092—00
20100—00
20110—00
20122—00
20130—00
20140—00
20150—150
20161—00
20170—00
20180—00
20190—01
20200—00
20210—10
20220—00
20230—00
20240—11
20250—00
20260—0—

What is it indicated for?

The IMMAGE Immunochemistry System Beta-2-Microglobulin (B2M) Reagent, when used in conjunction with Beckman IMMAGE™ Immunochemistry Systems and Beckman Calibrator 2, is intended for the quantitative determination of human beta-2-microglobulin in serum by rate nephelometry.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K973813: Immunochemistry System Beta-2-Microglobulin Reagent.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K973813

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026